BEGIN:VCALENDAR
PRODID:-//Pixl8//Eventfolio//EN
VERSION:2.0
X-WR-TIMEZONE:Europe/London
CALSCALE:GREGORIAN
METHOD:PUBLISH
CLASS:PUBLIC
BEGIN:VTIMEZONE
TZID:Europe/London
LAST-MODIFIED:20260306T231828Z
TZURL:https://www.tzurl.org/zoneinfo-outlook/Europe/London
X-LIC-LOCATION:Europe/London
BEGIN:DAYLIGHT
TZNAME:BST
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
DTSTART:19700329T010000
RRULE:FREQ=YEARLY;BYMONTH=3;BYDAY=-1SU
END:DAYLIGHT
BEGIN:STANDARD
TZNAME:GMT
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
DTSTART:19701025T020000
RRULE:FREQ=YEARLY;BYMONTH=10;BYDAY=-1SU
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20260610T170000
DTEND;TZID=Europe/London:20260610T200000
DTSTAMP:20260511T133509Z
UID:{7EAAEF51-68BC-4C29-A8E2C33BAD7740C8}
LOCATION:Thirteen Ldn\, 1-3 Denmark St\, London\, WC2H 8LP
SUMMARY:Capital for Cures Liquidity Event: Royalty Financing
DESCRIPTION:SS&C Intralinks  and Capital for Cures host an evening in London on 10 June 2026 focused on royalty financing. Globally a $20B+ annual market, royalty financing allows biotech and pharma companies to raise capital by selling a share of future product revenues, without diluting shareholders or taking on traditional debt. The mechanism has become a core part of the US life sciences funding stack, while European biotechs remain underserved and most deal flow continues to concentrate in North America. The evening brings together biotech executives, pharma BD teams, family offices, and specialist investors actively deploying into European royalty deals, featuring a moderated panel followed by extended networking.\n
 \n
 Event details: https://www.bioindustry.org/events/our-events/capital-for-cures-liquidity-event-royalty-financing.html
PRIORITY:1
END:VEVENT
END:VCALENDAR